Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-09

Clinical Trial Update: Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on apatinib as maintenance therapy after adjuvant chemotherapy in progressive gastric cancer with positive exfoliative cancer cells, spann…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apatinib (apatinib)

Snippet

Sponsor: Hebei Medical University | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: UNKNOWN